Glucagon test in insulinoma: Is it useful?
Carregando...
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
EDITRICE KURTIS S R L
Autores
FELICIO, J. S.
MARTINS, C. L. L. P.
MILEO, K. B.
SEMER, M.
KALININ, L.
LIBERMAN, B.
Citação
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, v.35, n.6, p.570-572, 2012
Resumo
Diagnosis of endogenous hyperinsulinism caused by insulinoma is based on confirmation of hypoglycemia during the symptoms associated to elevated insulin levels. Patients with insulinoma may demonstrate an excessive insulin response and subsequent hypoglycemia after 1 mg of glucagon iv injection. Glucagon test was performed in 11 patients with insulinoma before therapy and in 4 after therapy. Our study suggests that the presence of plasma glucose levels less than 55 mg/dl and below baseline at time 120 min of glucagon test strongly reinforce the diagnosis of insulinoma. (J. Endocrinol. Invest. 35: 570-572, 2012) (C) 2012, Editrice Kurtis
Palavras-chave
Hyperinsulinism, hypoglycemia, insulinoma
Referências
- Balcells A., 2002, CLIN LAB INTERPRETAC, P418
- Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410
- FAJANS SS, 1989, ENDOCRIN METAB CLIN, V18, P45
- FIELD JB, 1989, ENDOCRIN METAB CLIN, V18, P27
- JOHANSEN K, 1979, J ENDOCRINOL INVEST, V2, P285
- Kaltsas GA, 2004, ENDOCR REV, V25, P458, DOI 10.1210/er.2003-0014
- Kar P, 2006, J CLIN ENDOCR METAB, V91, P4733, DOI 10.1210/jc.2006-1430
- MARKS V, 1968, J CLIN PATHOL, V21, P346, DOI 10.1136/jcp.21.3.346
- PUN KK, 1988, J CLIN ENDOCR METAB, V67, P546
- SERVICE FJ, 1995, NEW ENGL J MED, V332, P1144, DOI 10.1056/NEJM199504273321707
- Service FJ., 1983, HYPOGLYCEMIC DISORDE
- STEFANIN.P, 1974, SURGERY, V75, P597
- Vezzosi D, 2007, EUR J ENDOCRINOL, V157, P75, DOI 10.1530/EJE-07-0109